Cerevel Therapeutics Holdings Inc (CERE)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: CERE Exchange: NAS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-07-03	2024-07-01	PS Planned sale	COLES N ANTHONY Non-Executive Director	25,000 -49.1% 41.18 USD 1,029,535	25,000 -49.1%	41.18	USD 1,029,535
2024-06-05	2024-06-03	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -76.2% 40.61 USD 2,030,520	50,000 -76.2%	40.61	USD 2,030,520
2024-05-14	2024-05-10	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -76.2% 42.10 USD 2,105,125	50,000 -76.2%	42.10	USD 2,105,125
2024-04-03	2024-04-01	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -76.2% 42.33 USD 2,116,640	50,000 -76.2%	42.33	USD 2,116,640
2024-03-06	2024-03-04	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -76.2% 41.01 USD 2,050,550	50,000 -76.2%	41.01	USD 2,050,550
2024-03-04	2024-02-29	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -76.2% 41.16 USD 2,057,890	50,000 -76.2%	41.16	USD 2,057,890
2024-02-08	2024-02-07	S Sale	COLES N ANTHONY Non-Executive Director	2,506 -13.8% 41.54 USD 104,110	2,506 -13.8%	41.54	USD 104,110
2024-02-08	2024-02-07	S Sale	Renger John Chief Scientific Officer Officer	2,161 -25.3% 41.54 USD 89,777	2,161 -25.3%	41.54	USD 89,777
2024-01-04	2024-01-02	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -94.9% 42.24 USD 2,111,815	50,000 -94.9%	42.24	USD 2,111,815
2023-12-28	2023-12-26	PS Planned sale	Sanchez Ramiro Chief Medical Officer Officer	10,000 -40.5% 42.47 USD 424,700	10,000 -40.5%	42.47	USD 424,700
2023-12-27	2023-12-22	S Sale	DiPietro Kenneth Chief Human Resources Officer Officer	8,000 -24.5% 41.45 USD 331,608	8,000 -24.5%	41.45	USD 331,608
2023-12-21	2023-12-20	S Sale	Akamine Scott Chief Legal Officer Officer	7,072 -49.4% 41.42 USD 292,945	7,072 -49.4%	41.42	USD 292,945
2023-12-21	2023-12-20	S Sale	Bodenrader Mark See Remarks Officer	7,889 -30.8% 41.42 USD 326,788	7,889 -30.8%	41.42	USD 326,788
2023-12-21	2023-12-20	S Sale	Tregoning Kathleen See Remarks Officer	6,288 -45.6% 41.42 USD 260,469	6,288 -45.6%	41.42	USD 260,469
2023-12-21	2023-12-20	S Sale	ALTSCHULLER Susan Chief Financial Officer Officer	13,808 -44.9% 41.42 USD 571,972	13,808 -44.9%	41.42	USD 571,972
2023-12-21	2023-12-20	S Sale	Sanchez Ramiro Chief Medical Officer Officer	10,152 -40.9% 41.42 USD 420,528	10,152 -40.9%	41.42	USD 420,528
2023-12-21	2023-12-20	S Sale	DiPietro Kenneth Chief Human Resources Officer Officer	6,256 -20.2% 41.42 USD 259,144	6,256 -20.2%	41.42	USD 259,144
2023-12-19	2023-12-15	S Sale	Sanchez Ramiro Chief Medical Officer Officer	7,500 -100.0% 41.39 USD 310,393	7,500 -100.0%	41.39	USD 310,393
2023-12-11	2023-12-07	PS Planned sale	Sanchez Ramiro Chief Medical Officer Officer	10,000 -100.0% 41.37 USD 413,700	10,000 -100.0%	41.37	USD 413,700
2023-12-07	2023-12-07	PS Planned sale	Akamine Scott Chief Legal Officer Officer	10,000 -95.1% 41.37 USD 413,700	10,000 -95.1%	41.37	USD 413,700
2023-12-07	2023-12-05	PS Planned sale	Akamine Scott Chief Legal Officer Officer	7,500 -93.6% 35.00 USD 262,500	7,500 -93.6%	35.00	USD 262,500
2023-11-16	2023-11-14	PS Planned sale	COLES N ANTHONY Non-Executive Director	22,824 -89.4% 25.13 USD 573,455	22,824 -89.4%	25.13	USD 573,455
2023-11-09	2023-11-08	PS Planned sale	COLES N ANTHONY Non-Executive Director	100 -3.6% 25.16 USD 2,516	100 -3.6%	25.16	USD 2,516
2023-11-09	2023-11-07	PS Planned sale	COLES N ANTHONY Non-Executive Director	27,076 -90.9% 25.02 USD 677,555	27,076 -90.9%	25.02	USD 677,555
2023-11-06	2023-11-03	PS Planned sale	COLES N ANTHONY Non-Executive Director	61,401 -95.8% 25.43 USD 1,561,458	61,401 -95.8%	25.43	USD 1,561,458
2023-11-06	2023-11-02	PS Planned sale	COLES N ANTHONY Non-Executive Director	38,599 -93.5% 25.19 USD 972,239	38,599 -93.5%	25.19	USD 972,239
2023-11-03	2023-11-01	PS Planned sale	PATRICK DEVAL L Non-Executive Director	30,130 -90.2% 25.00 USD 753,250	30,130 -90.2%	25.00	USD 753,250
2023-10-18	2023-10-16	B Purchase	BAIN CAPITAL INVESTORS LLC Large shareholder	5,480,052 +9.1% 22.81 USD 124,999,986	5,480,052 +9.1%	22.81	USD 124,999,986
2023-10-18	2023-10-16	B Purchase	Koppel Adam Non-Executive Director Large shareholder	5,480,052 +9.1% 22.81 USD 124,999,986	5,480,052 +9.1%	22.81	USD 124,999,986
2023-10-18	2023-10-16	B Purchase	Gordon Christopher R Non-Executive Director Large shareholder	5,480,052 +9.1% 22.81 USD 124,999,986	5,480,052 +9.1%	22.81	USD 124,999,986
2023-10-17	2023-10-16	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director	876,808 +8.8% 22.81 USD 19,999,990	876,808 +8.8%	22.81	USD 19,999,990
2023-09-08	2023-09-07	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -94.9% 24.07 USD 1,203,415	50,000 -94.9%	24.07	USD 1,203,415
2023-08-07	2023-08-04	B Purchase	Burgess Paul D. See Remarks Officer	21,880 +inf% 22.93 USD 501,794	21,880 +inf%	22.93	USD 501,794
2023-08-07	2023-08-03	B Purchase	Renaud Ronald C JR President & CEO Executive Director	83,857 +inf% 23.96 USD 2,008,811	83,857 +inf%	23.96	USD 2,008,811
2023-07-13	2023-07-11	PS Planned sale	COLES N ANTHONY Non-Executive Director	50,000 -94.9% 30.03 USD 1,501,340	50,000 -94.9%	30.03	USD 1,501,340
2023-06-20	2023-06-15	S Sale	DEKKERS MARIJN E Non-Executive Director	200,000 -33.2% 34.43 USD 6,886,000	200,000 -33.2%	34.43	USD 6,886,000
2023-06-05	2023-06-02	PS Planned sale	Bodenrader Mark See Remarks Officer	1,895 -25.5% 32.95 USD 62,440	1,895 -25.5%	32.95	USD 62,440
2023-06-05	2023-06-01	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	50,000 -94.9% 32.60 USD 1,630,070	50,000 -94.9%	32.60	USD 1,630,070
2023-05-08	2023-05-04	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	300 -10.0% 32.93 USD 9,879	300 -10.0%	32.93	USD 9,879
2023-05-08	2023-05-04	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	12,132 -80.2% 31.76 USD 385,287	12,132 -80.2%	31.76	USD 385,287
2023-05-08	2023-05-04	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	37,568 -71.3% 31.36 USD 1,178,268	37,568 -71.3%	31.36	USD 1,178,268
2023-04-13	2023-04-11	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	50,000 -94.9% 25.06 USD 1,253,130	50,000 -94.9%	25.06	USD 1,253,130
2023-03-06	2023-03-03	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	3,000 -52.6% 27.19 USD 81,570	3,000 -52.6%	27.19	USD 81,570
2023-03-06	2023-03-02	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	47,000 -94.6% 27.11 USD 1,274,377	47,000 -94.6%	27.11	USD 1,274,377
2023-02-08	2023-02-07	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	7,942 -74.6% 33.57 USD 266,649	7,942 -74.6%	33.57	USD 266,649
2023-02-08	2023-02-07	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	42,058 -79.8% 33.04 USD 1,389,752	42,058 -79.8%	33.04	USD 1,389,752
2023-01-06	2023-01-05	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	500 -15.6% 30.73 USD 15,366	500 -15.6%	30.73	USD 15,366
2023-01-06	2023-01-05	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	49,500 -93.9% 29.93 USD 1,481,505	49,500 -93.9%	29.93	USD 1,481,505
2022-12-13	2022-12-09	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	5,145 -65.5% 27.09 USD 139,395	5,145 -65.5%	27.09	USD 139,395
2022-12-13	2022-12-09	PS Planned sale	COLES N ANTHONY CEO and Chairperson Executive Director	44,855 -85.1% 26.62 USD 1,193,906	44,855 -85.1%	26.62	USD 1,193,906
2022-11-03	2022-11-01	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -90.2% 30.00 USD 750,005	25,000 -90.2%	30.00	USD 750,005
2022-10-06	2022-10-04	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -90.2% 30.00 USD 750,000	25,000 -90.2%	30.00	USD 750,000
2022-09-14	2022-09-12	PS Planned sale	PATRICK DEVAL L Non-Executive Director	47,705 -100.0% 30.78 USD 1,468,422	47,705 -100.0%	30.78	USD 1,468,422
2022-09-12	2022-09-08	PS Planned sale	Ceesay Abraham President Officer	19,210 -100.0% 32.50 USD 624,325	19,210 -100.0%	32.50	USD 624,325
2022-08-24	2022-08-22	PS Planned sale	Ceesay Abraham President Officer	9,605 -100.0% 32.50 USD 312,163	9,605 -100.0%	32.50	USD 312,163
2022-08-18	2022-08-16	B Purchase	PERCEPTIVE ADVISORS LLC Non-Executive Director	1,425,000 +28.0% 35.00 USD 49,875,000	1,425,000 +28.0%	35.00	USD 49,875,000
2022-08-17	2022-08-15	PS Planned sale	Ceesay Abraham President Officer	9,606 -100.0% 34.12 USD 327,757	9,606 -100.0%	34.12	USD 327,757
2022-08-12	2022-08-10	PS Planned sale	Renger John Chief Scientific Officer Officer	18,859 -87.5% 41.10 USD 775,092	18,859 -87.5%	41.10	USD 775,092
2022-08-12	2022-08-10	PS Planned sale	Renger John Chief Scientific Officer Officer	36,141 -62.6% 40.19 USD 1,452,532	36,141 -62.6%	40.19	USD 1,452,532
2022-08-09	2022-08-08	PS Planned sale	Renger John Chief Scientific Officer Officer	10,000 -78.7% 37.75 USD 377,500	10,000 -78.7%	37.75	USD 377,500
2022-08-09	2022-08-08	PS Planned sale	Akamine Scott Chief Legal Officer Officer	10,000 -100.0% 40.00 USD 400,001	10,000 -100.0%	40.00	USD 400,001
2022-08-09	2022-08-08	PS Planned sale	Ceesay Abraham President Officer	9,605 -100.0% 39.50 USD 379,398	9,605 -100.0%	39.50	USD 379,398
2022-08-09	2022-08-08	PS Planned sale	Ceesay Abraham President Officer	9,606 -50.0% 37.75 USD 362,627	9,606 -50.0%	37.75	USD 362,627
2022-08-09	2022-08-05	PS Planned sale	Renger John Chief Scientific Officer Officer	20,000 -88.1% 32.50 USD 650,000	20,000 -88.1%	32.50	USD 650,000
2022-08-09	2022-08-05	PS Planned sale	Ceesay Abraham President Officer	38,424 -100.0% 32.50 USD 1,248,780	38,424 -100.0%	32.50	USD 1,248,780
2022-07-22	2022-07-20	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -90.2% 30.00 USD 750,000	25,000 -90.2%	30.00	USD 750,000
2022-07-07	2022-07-06	PS Planned sale	Renger John Chief Scientific Officer Officer	1,105 -29.0% 32.50 USD 35,913	1,105 -29.0%	32.50	USD 35,913
2022-07-07	2022-07-05	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -90.2% 30.00 USD 750,000	25,000 -90.2%	30.00	USD 750,000
2022-04-15	2022-04-13	PS Planned sale	Renger John Chief Scientific Officer Officer	45,000 -95.8% 34.65 USD 1,559,093	45,000 -95.8%	34.65	USD 1,559,093
2022-03-18	2022-03-18	PS Planned sale	Renger John Chief Scientific Officer Officer	20,000 -91.0% 32.50 USD 650,004	20,000 -91.0%	32.50	USD 650,004
2022-03-18	2022-03-16	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -92.7% 30.00 USD 750,005	25,000 -92.7%	30.00	USD 750,005
2022-03-11	2022-03-09	PS Planned sale	Renger John Chief Scientific Officer Officer	10,000 -83.5% 35.00 USD 350,000	10,000 -83.5%	35.00	USD 350,000
2022-03-11	2022-03-09	PS Planned sale	Renger John Chief Scientific Officer Officer	20,000 -62.5% 32.50 USD 650,000	20,000 -62.5%	32.50	USD 650,000
2022-03-04	2022-03-02	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -92.7% 30.00 USD 750,000	25,000 -92.7%	30.00	USD 750,000
2022-02-11	2022-02-09	PS Planned sale	Renger John Chief Scientific Officer Officer	25,000 -92.7% 30.00 USD 750,000	25,000 -92.7%	30.00	USD 750,000

Cerevel Therapeutics Holdings Inc (CERE)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by